| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 8.19e-05 | 32 | 145 | 4 | GO:0140142 | |
| GeneOntologyBiologicalProcess | regulation of Rab protein signal transduction | 6.84e-06 | 6 | 146 | 3 | GO:0032483 | |
| HumanPheno | Increased circulating osteocalcin level | 1.17e-05 | 5 | 55 | 3 | HP:0031428 | |
| MousePheno | hyposulfatemia | 5.91e-05 | 2 | 108 | 2 | MP:0002853 | |
| MousePheno | abnormal circulating sulfate level | 5.91e-05 | 2 | 108 | 2 | MP:0002851 | |
| MousePheno | abnormal urine sulfate level | 5.91e-05 | 2 | 108 | 2 | MP:0009471 | |
| MousePheno | increased urine sulfate level | 5.91e-05 | 2 | 108 | 2 | MP:0009472 | |
| Domain | ARM-type_fold | TNPO1 USP34 TNPO2 USP24 TSC2 APOB FRYL PACRGL PELP1 ARVCF XPO5 NBEAL2 NUP188 STAG3 KPNA2 | 4.36e-08 | 339 | 141 | 15 | IPR016024 |
| Domain | ARM-like | TNPO1 TNPO2 TSC2 FRYL PACRGL PELP1 ARVCF XPO5 NBEAL2 STAG3 KPNA2 | 6.58e-06 | 270 | 141 | 11 | IPR011989 |
| Domain | - | 4.85e-05 | 222 | 141 | 9 | 1.25.10.10 | |
| Domain | Gamma_tubulin | 5.66e-05 | 2 | 141 | 2 | IPR002454 | |
| Domain | BACK | 8.93e-05 | 60 | 141 | 5 | SM00875 | |
| Domain | BACK | 9.67e-05 | 61 | 141 | 5 | IPR011705 | |
| Domain | BACK | 9.67e-05 | 61 | 141 | 5 | PF07707 | |
| Domain | uDENN | 1.79e-04 | 15 | 141 | 3 | PF03456 | |
| Domain | DENN | 2.19e-04 | 16 | 141 | 3 | SM00799 | |
| Domain | IBN_N | 2.19e-04 | 16 | 141 | 3 | SM00913 | |
| Domain | DENN | 2.19e-04 | 16 | 141 | 3 | PF02141 | |
| Domain | dDENN | 2.19e-04 | 16 | 141 | 3 | PF03455 | |
| Domain | UDENN | 2.19e-04 | 16 | 141 | 3 | PS50946 | |
| Domain | DDENN | 2.19e-04 | 16 | 141 | 3 | PS50947 | |
| Domain | dDENN | 2.19e-04 | 16 | 141 | 3 | SM00801 | |
| Domain | dDENN_dom | 2.19e-04 | 16 | 141 | 3 | IPR005112 | |
| Domain | uDENN_dom | 2.19e-04 | 16 | 141 | 3 | IPR005113 | |
| Domain | DENN | 2.19e-04 | 16 | 141 | 3 | PS50211 | |
| Domain | DENN_dom | 2.19e-04 | 16 | 141 | 3 | IPR001194 | |
| Domain | Importin-beta_N | 2.65e-04 | 17 | 141 | 3 | IPR001494 | |
| Domain | SOCS | 4.37e-04 | 20 | 141 | 3 | SM00253 | |
| Domain | UbiB_dom | 5.58e-04 | 5 | 141 | 2 | IPR004147 | |
| Domain | ABC1 | 5.58e-04 | 5 | 141 | 2 | PF03109 | |
| Domain | AAA | 7.90e-04 | 144 | 141 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 7.90e-04 | 144 | 141 | 6 | IPR003593 | |
| Domain | PLA2_B | 1.16e-03 | 7 | 141 | 2 | PF01735 | |
| Domain | PLA2C | 1.16e-03 | 7 | 141 | 2 | PS51210 | |
| Domain | LysoPLipase_cat_dom | 1.16e-03 | 7 | 141 | 2 | IPR002642 | |
| Domain | Carbohydrate_sulfotransferase | 1.16e-03 | 7 | 141 | 2 | IPR016469 | |
| Domain | PLAc | 1.16e-03 | 7 | 141 | 2 | SM00022 | |
| Domain | VPS9 | 1.54e-03 | 8 | 141 | 2 | SM00167 | |
| Domain | - | WSCD1 DNAH10 LONP2 PEX6 CHST6 DDX56 TEP1 RUVBL2 ABCA7 RAB40AL RAB40B CHST2 ASCC3 ELP4 | 1.55e-03 | 746 | 141 | 14 | 3.40.50.300 |
| Domain | Arm | 1.62e-03 | 31 | 141 | 3 | PF00514 | |
| Domain | BEACH | 1.97e-03 | 9 | 141 | 2 | PS50197 | |
| Domain | Beach | 1.97e-03 | 9 | 141 | 2 | PF02138 | |
| Domain | - | 1.97e-03 | 9 | 141 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.97e-03 | 9 | 141 | 2 | SM01026 | |
| Domain | BEACH_dom | 1.97e-03 | 9 | 141 | 2 | IPR000409 | |
| Domain | VPS9 | 2.45e-03 | 10 | 141 | 2 | PS51205 | |
| Domain | VPS9 | 2.45e-03 | 10 | 141 | 2 | PF02204 | |
| Domain | VPS9 | 2.45e-03 | 10 | 141 | 2 | IPR003123 | |
| Domain | Sulfotransfer_1 | 2.51e-03 | 36 | 141 | 3 | PF00685 | |
| Domain | Sulfotransferase_dom | 2.51e-03 | 36 | 141 | 3 | IPR000863 | |
| Domain | SOCS_box | 2.93e-03 | 38 | 141 | 3 | PF07525 | |
| Domain | SOCS_box | 3.16e-03 | 39 | 141 | 3 | SM00969 | |
| Domain | SOCS_box | 3.16e-03 | 39 | 141 | 3 | IPR001496 | |
| Domain | SOCS | 3.16e-03 | 39 | 141 | 3 | PS50225 | |
| Domain | BTB | 3.18e-03 | 131 | 141 | 5 | PF00651 | |
| Domain | BTB-kelch_protein | 4.17e-03 | 43 | 141 | 3 | IPR017096 | |
| Domain | IMPORTIN_B_NT | 4.85e-03 | 14 | 141 | 2 | PS50166 | |
| Domain | uDENN | 4.85e-03 | 14 | 141 | 2 | SM00800 | |
| Domain | P-loop_NTPase | WSCD1 DNAH10 LONP2 PEX6 CHST6 DDX56 TEP1 RUVBL2 ABCA7 RAB40AL RAB40B CHST2 ASCC3 ELP4 | 4.93e-03 | 848 | 141 | 14 | IPR027417 |
| Domain | Armadillo | 5.36e-03 | 47 | 141 | 3 | IPR000225 | |
| Domain | IBN_N | 5.57e-03 | 15 | 141 | 2 | PF03810 | |
| Domain | - | 5.68e-03 | 48 | 141 | 3 | 2.120.10.80 | |
| Domain | Integrin_alpha_C_CS | 6.34e-03 | 16 | 141 | 2 | IPR018184 | |
| Domain | AAA | 7.11e-03 | 52 | 141 | 3 | PF00004 | |
| Domain | Acyl_Trfase/lysoPLipase | 7.15e-03 | 17 | 141 | 2 | IPR016035 | |
| Domain | BTB | 7.37e-03 | 160 | 141 | 5 | PS50097 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 TRPM4 SPIRE2 PEX6 DDX56 TSC2 FRYL ITGA3 COMTD1 IDUA TEP1 PLEKHG5 ABCA7 TUBG1 MADD ARHGEF40 KLHL25 RPAP1 SH3TC1 ARVCF BTBD7 NBEAL2 NUP188 DOCK6 | 4.86e-11 | 1105 | 147 | 24 | 35748872 |
| Pubmed | Piezo mechanosensory channels regulate centrosome integrity and mitotic entry. | 2.95e-07 | 4 | 147 | 3 | 36574677 | |
| Pubmed | LONP2 ORC3 PEX6 EXOC3 RUVBL2 DENND3 MADD ARHGEF40 RPAP1 ARVCF AP5B1 CARD6 SCRIB LRRC41 | 7.51e-07 | 650 | 147 | 14 | 38777146 | |
| Pubmed | USP34 COQ8B PEX6 DDX56 ITGA3 DCAF16 TEP1 PLEKHN1 RUVBL2 ABCA7 TUBG1 ARHGEF40 TCHH SH3TC1 NUP188 SCRIB ASCC3 LRRC41 | 1.25e-06 | 1116 | 147 | 18 | 31753913 | |
| Pubmed | 1.47e-06 | 6 | 147 | 3 | 38546045 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TNPO1 NAT14 USP24 TSC2 SAMHD1 DCAF16 TUBG1 LRRC47 ARHGEF40 RPAP1 XPO5 NUP188 SCRIB ASCC3 MAP3K7 KPNA2 | 2.64e-06 | 942 | 147 | 16 | 31073040 |
| Pubmed | 4.26e-06 | 26 | 147 | 4 | 23181366 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TRPM4 NAT14 WDR81 COMTD1 PLEKHN1 MADD RIN1 XPO5 FDXR FGA LRPAP1 SCRIB MAP4K2 | 1.25e-05 | 719 | 147 | 13 | 35337019 |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 39044278 | ||
| Pubmed | MTOC reorientation occurs during FcgammaR-mediated phagocytosis in macrophages. | 1.77e-05 | 2 | 147 | 2 | 17442887 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 22806905 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 37252981 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 25075558 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 17287496 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 27412988 | ||
| Pubmed | Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins. | 1.77e-05 | 2 | 147 | 2 | 9298975 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 36912451 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28119396 | ||
| Pubmed | Transportin-1 and Transportin-2: protein nuclear import and beyond. | 1.77e-05 | 2 | 147 | 2 | 24780099 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 29893327 | ||
| Pubmed | Diagnostic and prognostic significance of CA IX and suPAR in gastric cancer. | 1.77e-05 | 2 | 147 | 2 | 23512428 | |
| Pubmed | Gene knockout analysis of two gamma-tubulin isoforms in mice. | 1.77e-05 | 2 | 147 | 2 | 15893303 | |
| Pubmed | TNPO1 USP24 SAMHD1 RUVBL2 TUBG1 LRRC47 PELP1 XPO5 NUP188 SCRIB ASCC3 KPNA2 | 1.85e-05 | 638 | 147 | 12 | 33239621 | |
| Pubmed | 2.75e-05 | 41 | 147 | 4 | 12076535 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | TRPM4 TRPM7 SLCO2B1 EXOC3 APOB ITGA3 PLEKHN1 PIEZO2 ARVCF NBEAL2 SCRIB | 3.26e-05 | 569 | 147 | 11 | 30639242 |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 24992337 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 17114179 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 19124606 | ||
| Pubmed | RIP3 antagonizes a TSC2-mediated pro-survival pathway in glioblastoma cell death. | 5.31e-05 | 3 | 147 | 2 | 27984090 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 7604027 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 24712655 | ||
| Pubmed | Nuclear entry of high-risk human papillomavirus type 16 E6 oncoprotein occurs via several pathways. | 5.31e-05 | 3 | 147 | 2 | 12551970 | |
| Pubmed | TAK1 regulates endothelial cell necroptosis and tumor metastasis. | 5.31e-05 | 3 | 147 | 2 | 30683914 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 10903841 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 16510444 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 19034549 | ||
| Pubmed | The stem region of the sulfotransferase GlcNAc6ST-1 is a determinant of substrate specificity. | 5.31e-05 | 3 | 147 | 2 | 15220337 | |
| Pubmed | Human TUBG2 gene is expressed as two splice variant mRNA and involved in cell growth. | 5.31e-05 | 3 | 147 | 2 | 27015882 | |
| Pubmed | Characterization of the human homologue of the yeast spc98p and its association with gamma-tubulin. | 5.31e-05 | 3 | 147 | 2 | 9566969 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 23972991 | ||
| Pubmed | ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. | 5.31e-05 | 3 | 147 | 2 | 20606625 | |
| Pubmed | The Aurora A-HP1γ pathway regulates gene expression and mitosis in cells from the sperm lineage. | 5.31e-05 | 3 | 147 | 2 | 26021315 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 30975711 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 11278593 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 15976002 | ||
| Pubmed | Involvement of transportin 2-mediated HuR import in muscle cell differentiation. | 5.31e-05 | 3 | 147 | 2 | 17475777 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 12748857 | ||
| Pubmed | 5.76e-05 | 18 | 147 | 3 | 23726366 | ||
| Pubmed | 6.27e-05 | 407 | 147 | 9 | 12693553 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TNPO2 COQ8B TSC2 SAMHD1 LRRC47 RPAP1 DENND4B PCIF1 PITPNM3 NUP188 SCRIB ELP4 | 7.34e-05 | 736 | 147 | 12 | 29676528 |
| Pubmed | SORBS2 ORC3 FN3KRP DDX56 SAMHD1 PLEKHN1 RUVBL2 KLHL25 ELN ASCC3 BAIAP3 ELP4 | 8.77e-05 | 750 | 147 | 12 | 11230166 | |
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 9.06e-05 | 106 | 147 | 5 | 31024071 | |
| Pubmed | 9.30e-05 | 21 | 147 | 3 | 25521757 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 24036114 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 20164345 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 10875935 | ||
| Pubmed | Targeting of nonexpressed genes in embryonic stem cells via homologous recombination. | 1.06e-04 | 4 | 147 | 2 | 2506639 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 15346842 | ||
| Pubmed | Genetic Interactions Between the Meiosis-Specific Cohesin Components, STAG3, REC8, and RAD21L. | 1.06e-04 | 4 | 147 | 2 | 27172213 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 32071228 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 29724914 | ||
| Pubmed | Loss of Necdin impairs myosin activation and delays cell polarization. | 1.06e-04 | 4 | 147 | 2 | 20665884 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 9891055 | ||
| Pubmed | Karyopherin beta 2B participates in mRNA export from the nucleus. | 1.06e-04 | 4 | 147 | 2 | 12384575 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 28192541 | ||
| Pubmed | Aspm specifically maintains symmetric proliferative divisions of neuroepithelial cells. | 1.06e-04 | 4 | 147 | 2 | 16798874 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 10769753 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 15507604 | ||
| Pubmed | Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR. | 1.06e-04 | 4 | 147 | 2 | 15037768 | |
| Pubmed | TNPO1 USP34 USP24 DDX56 FRYL LRRC47 PELP1 XPO5 NUP188 ASCC3 STOML2 | 1.11e-04 | 653 | 147 | 11 | 22586326 | |
| Pubmed | 1.23e-04 | 23 | 147 | 3 | 33130828 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TNPO1 USP34 DCPS USP24 ZC3HC1 FRYL SAMHD1 SMOC1 TYMP RUVBL2 TUBG1 LRRC47 LIG1 XPO5 NUP188 ELP4 KPNA2 | 1.48e-04 | 1455 | 147 | 17 | 22863883 |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 1.56e-04 | 119 | 147 | 5 | 35776542 | |
| Pubmed | Primary cilia dynamics instruct tissue patterning and repair of corneal endothelium. | 1.76e-04 | 5 | 147 | 2 | 21285373 | |
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 30853435 | ||
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 19251731 | ||
| Pubmed | The essential role of centrosomal NDE1 in human cerebral cortex neurogenesis. | 1.76e-04 | 5 | 147 | 2 | 21529752 | |
| Pubmed | Monocilia in the embryonic mouse heart suggest a direct role for cilia in cardiac morphogenesis. | 1.76e-04 | 5 | 147 | 2 | 18729223 | |
| Pubmed | WDR62 is associated with the spindle pole and is mutated in human microcephaly. | 1.76e-04 | 5 | 147 | 2 | 20890279 | |
| Pubmed | Speriolin is a novel human and mouse sperm centrosome protein. | 1.76e-04 | 5 | 147 | 2 | 20542897 | |
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 25877302 | ||
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 29244804 | ||
| Pubmed | Mutations in the Heterotopia Gene Eml1/EML1 Severely Disrupt the Formation of Primary Cilia. | 1.76e-04 | 5 | 147 | 2 | 31390572 | |
| Pubmed | STAG2 and Rad21 mammalian mitotic cohesins are implicated in meiosis. | 1.76e-04 | 5 | 147 | 2 | 12034751 | |
| Pubmed | A two-kinesin mechanism controls neurogenesis in the developing brain. | 1.76e-04 | 5 | 147 | 2 | 38040957 | |
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 16751367 | ||
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 15680357 | ||
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 15342649 | ||
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 37100289 | ||
| Pubmed | Intranuclear binding by the HIV-1 regulatory protein VPR is dependent on cytosolic factors. | 1.76e-04 | 5 | 147 | 2 | 10772949 | |
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 30867513 | ||
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 27909076 | ||
| Pubmed | Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. | 1.76e-04 | 5 | 147 | 2 | 9817747 | |
| Pubmed | Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. | 1.76e-04 | 5 | 147 | 2 | 30361383 | |
| Pubmed | HIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomes. | 1.76e-04 | 5 | 147 | 2 | 14767062 | |
| Pubmed | Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. | 1.76e-04 | 5 | 147 | 2 | 28842570 | |
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 9405152 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TNPO1 ORC3 USP24 ZC3HC1 RUVBL2 TUBG1 LRRC47 XPO5 SCRIB KPNA2 | 1.95e-04 | 582 | 147 | 10 | 20467437 |
| Pubmed | 2.07e-04 | 282 | 147 | 7 | 23667531 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | SAMHD1 RUVBL2 LRRC47 LIG1 RPAP1 FDXR NUP188 SCRIB ASCC3 TBC1D23 STOML2 | 2.13e-04 | 704 | 147 | 11 | 29955894 |
| Interaction | TOP3B interactions | USP34 TRPM4 SPIRE2 PEX6 DDX56 TSC2 APOB FRYL ITGA3 COMTD1 IDUA TEP1 PLEKHG5 ABCA7 TUBG1 MADD ARHGEF40 KLHL25 RPAP1 PELP1 SH3TC1 ARVCF XPO5 BTBD7 NBEAL2 NUP188 DOCK6 | 3.69e-06 | 1470 | 142 | 27 | int:TOP3B |
| Cytoband | 16q24 | 2.12e-05 | 17 | 147 | 3 | 16q24 | |
| Cytoband | 4p15.31 | 4.51e-04 | 10 | 147 | 2 | 4p15.31 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.54e-04 | 18 | 107 | 3 | 596 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.22e-04 | 25 | 107 | 3 | 504 | |
| GeneFamily | Cohesin complex | 9.49e-04 | 8 | 107 | 2 | 1060 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.21e-03 | 134 | 107 | 5 | 861 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.22e-03 | 9 | 107 | 2 | 1230 | |
| GeneFamily | VPS9 domain containing | 1.51e-03 | 10 | 107 | 2 | 928 | |
| GeneFamily | Kelch like|BTB domain containing | 1.96e-03 | 42 | 107 | 3 | 617 | |
| GeneFamily | AAA ATPases | 3.81e-03 | 53 | 107 | 3 | 413 | |
| GeneFamily | DNA helicases | 4.45e-03 | 17 | 107 | 2 | 1167 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 4.99e-03 | 18 | 107 | 2 | 1160 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-07 | 179 | 147 | 8 | 3d3716078afdb9a89ddfadb3197cd1b52fa770be | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-06 | 182 | 147 | 7 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-06 | 182 | 147 | 7 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-06 | 182 | 147 | 7 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-06 | 183 | 147 | 7 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-APOE+_Mac2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.78e-06 | 185 | 147 | 7 | 8f843badc0e26cb7300c83db56c7974beb90fcf3 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.32e-06 | 190 | 147 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.21e-06 | 197 | 147 | 7 | 67bf15ee83938bd40f6ecd5abaaf90ad95096d21 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 156 | 147 | 6 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 177 | 147 | 6 | 9c7c6824b9011363851f084a500d665f025b026e | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 177 | 147 | 6 | 2bf639e9e801e5144462ffc957f5739e0dfcd500 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-05 | 178 | 147 | 6 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 2.90e-05 | 179 | 147 | 6 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-05 | 182 | 147 | 6 | 21744c9c792e57d5d41b25986f419b2358c7057b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 182 | 147 | 6 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 182 | 147 | 6 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 182 | 147 | 6 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 184 | 147 | 6 | c86ed59fed687cdaaf7e9c4418d2e3e2c4111cca | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 184 | 147 | 6 | 7c256bcfa07c5ff55aad0833e8712b0456b5832b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.59e-05 | 186 | 147 | 6 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.59e-05 | 186 | 147 | 6 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 187 | 147 | 6 | 269145d71576cbe8fa217090c8aac82d915dbc04 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 187 | 147 | 6 | 7a50aded3243bef2075fb3ec550939ce0694919a | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.70e-05 | 187 | 147 | 6 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 187 | 147 | 6 | 629b3e05840eb10e598b8dfaabd92ebe02f9995a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-05 | 188 | 147 | 6 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 189 | 147 | 6 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 189 | 147 | 6 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 189 | 147 | 6 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.16e-05 | 191 | 147 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.29e-05 | 192 | 147 | 6 | 2f539653a20006bef814e6b4acd1023d6fdad5c6 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 4.29e-05 | 192 | 147 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.41e-05 | 193 | 147 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 4.54e-05 | 194 | 147 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.67e-05 | 195 | 147 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.67e-05 | 195 | 147 | 6 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-05 | 196 | 147 | 6 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-05 | 196 | 147 | 6 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.95e-05 | 197 | 147 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.95e-05 | 197 | 147 | 6 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.09e-05 | 198 | 147 | 6 | eb0a94c426a7c567f94490b848e28784587c6dcd | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-05 | 199 | 147 | 6 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | COVID-19-Myeloid-MoAM3,_VCAN|COVID-19 / Condition, Lineage and Cell class | 5.23e-05 | 199 | 147 | 6 | aba0b833e44fe42625fac91466f6ebaa8e786d3b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-05 | 199 | 147 | 6 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.23e-05 | 199 | 147 | 6 | 667b8b47a5b388506e3177b46747267fad8024f6 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Alveolar_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.38e-05 | 200 | 147 | 6 | 0ed49c2177b58269ff7653db6be7d68633a5d34a | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.38e-05 | 200 | 147 | 6 | 94bd00fb6ff0dcb668eb36ec2085f1c3128855b6 | |
| ToppCell | Control-Myeloid|Control / Condition, Lineage and Cell class | 5.38e-05 | 200 | 147 | 6 | 379f5de322beb7f8f8a58c1609c8f895f8285132 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.38e-05 | 200 | 147 | 6 | 4f624c3c57d1a84baa86d0830cb1b83ae110bf67 | |
| ToppCell | Biopsy_Other_PF-Immune-Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.38e-05 | 200 | 147 | 6 | 9ff5f0371aac2ab528b581fe979a1522579b8b84 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.38e-05 | 200 | 147 | 6 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | TCGA-Uvea|World / Sample_Type by Project: Shred V9 | 1.05e-04 | 141 | 147 | 5 | 015451a83087f2705d3315ebc8f23797c6f10ed6 | |
| ToppCell | droplet-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 145 | 147 | 5 | f142b86d4da5b71c189da46cbc4beebdc387ffee | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.45e-04 | 151 | 147 | 5 | def98dc2a8226295b62de2b7f1b587e03a4f038c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 153 | 147 | 5 | 0727dc70e16345645063c586d744bc4ac1710526 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Rostral-�migratory_stream-�(RMS)_(Hist1h2al))|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.57e-04 | 82 | 147 | 4 | 3cee9ee752128dd91e9abc05c9f97b17e64a2a76 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocyte.Tnr.Opalin_(Opalin)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.57e-04 | 82 | 147 | 4 | 5cd8e47edb775eabf3e9a407c1c2d8a78afb9509 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.57e-04 | 82 | 147 | 4 | 1eeb259ec555879ee1962b7bc2c31c200fbb85cf | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.59e-04 | 154 | 147 | 5 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.59e-04 | 154 | 147 | 5 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 154 | 147 | 5 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.59e-04 | 154 | 147 | 5 | b5604c0b0b9b283352a3f612f40883b9123475d1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.59e-04 | 154 | 147 | 5 | 160b170a3ade8b246843c9854af332475c047ba0 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.90e-04 | 160 | 147 | 5 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.90e-04 | 160 | 147 | 5 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.90e-04 | 160 | 147 | 5 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 161 | 147 | 5 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 161 | 147 | 5 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.25e-04 | 166 | 147 | 5 | 8ac0a769be886d16642e7e6334471ebadd1a426b | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.32e-04 | 167 | 147 | 5 | 806d1c00c137da0c5f042adf866873eb6dd4bb27 | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 167 | 147 | 5 | 7b1fd19946cee67dae68f0f0d98420abcd532482 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 168 | 147 | 5 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 168 | 147 | 5 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 168 | 147 | 5 | de1042267407719f19eb3f580a5df0c9cd0e8273 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 2.45e-04 | 169 | 147 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 171 | 147 | 5 | 6f49537f8d3cf18e65aa999fec32ed347ce2da3e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-04 | 171 | 147 | 5 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 171 | 147 | 5 | ab97ae2b127a585f170f028f1c475cdd1b0cdea5 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-04 | 171 | 147 | 5 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 172 | 147 | 5 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 172 | 147 | 5 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 173 | 147 | 5 | 295bfe1efa648173c2d5981025bc61c576baf53f | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 173 | 147 | 5 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 173 | 147 | 5 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 174 | 147 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | droplet-Heart-nan-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 174 | 147 | 5 | cf4e0567f2a4ebe5534046b1c091af59b55bdc4f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.80e-04 | 174 | 147 | 5 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 176 | 147 | 5 | d687e6c3f9043f2574d072f815b8c2258f9dc7b5 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 176 | 147 | 5 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | droplet-Kidney-nan-21m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 176 | 147 | 5 | 0475db3f860de1e216cbdeb886f7a75b9f4fc801 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 176 | 147 | 5 | 4f37854124d77ee64dcb40fd491eaed2ba389891 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 176 | 147 | 5 | 0afba8707b847e5bdf6f38fe4379967631fe2240 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-04 | 176 | 147 | 5 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.95e-04 | 176 | 147 | 5 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.03e-04 | 177 | 147 | 5 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.11e-04 | 178 | 147 | 5 | c90e9048fc786ba8559972ae25c25ecab4bc1b7c | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.11e-04 | 178 | 147 | 5 | 9e426ce23a4a33b91d139ad85685cf8483bcd01a | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.19e-04 | 179 | 147 | 5 | abc6797bd3884aa75dca58fcb2523ee321243ab1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.19e-04 | 179 | 147 | 5 | 0b996d6e881f31e6b80d359f7caac70ecdeb9982 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.19e-04 | 179 | 147 | 5 | f2e8fc975c30992611630197b79daaeef7c4211d | |
| Computational | Genes in the cancer module 245. | 3.23e-05 | 26 | 77 | 4 | MODULE_245 | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 4.98e-06 | 197 | 145 | 9 | 5589_DN | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 1uM; MCF7; HT_HG-U133A | 5.19e-06 | 198 | 145 | 9 | 4383_UP | |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.41e-06 | 199 | 145 | 9 | 2882_UP | |
| Disease | phosphatidylcholine 32:0 measurement | 1.79e-05 | 11 | 143 | 3 | EFO_0010372 | |
| Disease | intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (implicated_via_orthology) | 2.33e-05 | 2 | 143 | 2 | DOID:0081262 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 4 (implicated_via_orthology) | 2.33e-05 | 2 | 143 | 2 | DOID:0090138 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 9.15e-05 | 291 | 143 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | obsolete_red blood cell distribution width | TNPO1 KLHL24 ZC3HC1 APOB SAMHD1 SMOC1 ITGAD TYMP PLEKHG5 ABCA7 LRRC47 PIGQ SLC34A1 PCIF1 PLAUR CHST2 DOCK6 MUSK | 9.47e-05 | 1347 | 143 | 18 | EFO_0005192 |
| Disease | free cholesterol to total lipids in small HDL percentage | 1.11e-04 | 51 | 143 | 4 | EFO_0022285 | |
| Disease | phospholipids:total lipids ratio | 1.25e-04 | 227 | 143 | 7 | EFO_0020946 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 1.49e-04 | 55 | 143 | 4 | EFO_0022288 | |
| Disease | suntan | 1.49e-04 | 103 | 143 | 5 | EFO_0004279 | |
| Disease | age at menarche | WSCD1 USP34 ARHGAP40 HLF AFF3 ZC3HC1 MADD GPR83 PTPRD PDILT ASCC3 | 1.58e-04 | 594 | 143 | 11 | EFO_0004703 |
| Disease | triglycerides in large VLDL measurement | 1.60e-04 | 56 | 143 | 4 | EFO_0022178 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 1.60e-04 | 22 | 143 | 3 | EFO_0009312 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.64e-04 | 166 | 143 | 6 | EFO_0004530, EFO_0004611 | |
| Disease | high density lipoprotein particle size measurement | 1.86e-04 | 170 | 143 | 6 | EFO_0008592 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.91e-04 | 243 | 143 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.03e-04 | 110 | 143 | 5 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.03e-04 | 110 | 143 | 5 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 2.09e-04 | 60 | 143 | 4 | EFO_0022282 | |
| Disease | aortic valve stenosis (is_implicated_in) | 2.31e-04 | 5 | 143 | 2 | DOID:1712 (is_implicated_in) | |
| Disease | total lipids in very large VLDL measurement | 2.37e-04 | 62 | 143 | 4 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 2.37e-04 | 62 | 143 | 4 | EFO_0022299 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 2.67e-04 | 26 | 143 | 3 | OBA_2045191 | |
| Disease | cholesterol in very large VLDL measurement | 2.85e-04 | 65 | 143 | 4 | EFO_0022230 | |
| Disease | total lipids in large VLDL | 3.20e-04 | 67 | 143 | 4 | EFO_0022175 | |
| Disease | free cholesterol in large VLDL measurement | 3.39e-04 | 68 | 143 | 4 | EFO_0022265 | |
| Disease | aortic valve disease (implicated_via_orthology) | 3.45e-04 | 6 | 143 | 2 | DOID:62 (implicated_via_orthology) | |
| Disease | Symptomatic Infantile Spasms | 3.45e-04 | 6 | 143 | 2 | C0393699 | |
| Disease | Cryptogenic Infantile Spasms | 3.45e-04 | 6 | 143 | 2 | C0393698 | |
| Disease | Hypsarrhythmia | 3.45e-04 | 6 | 143 | 2 | C0684276 | |
| Disease | Salaam Seizures | 3.45e-04 | 6 | 143 | 2 | C1527366 | |
| Disease | ANEURYSM, INTRACRANIAL BERRY, 1 (disorder) | 3.45e-04 | 6 | 143 | 2 | C1862932 | |
| Disease | Nodding spasm | 3.45e-04 | 6 | 143 | 2 | C0546878 | |
| Disease | spasmus nutans | 3.45e-04 | 6 | 143 | 2 | C1527306 | |
| Disease | Jackknife Seizures | 3.45e-04 | 6 | 143 | 2 | C0553558 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 3.99e-04 | 71 | 143 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.11e-04 | 276 | 143 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | sphingomyelin measurement | 4.30e-04 | 278 | 143 | 7 | EFO_0010118 | |
| Disease | phospholipids in large HDL measurement | 4.44e-04 | 73 | 143 | 4 | EFO_0022190 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.45e-04 | 200 | 143 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | total lipids in large HDL | 4.68e-04 | 74 | 143 | 4 | EFO_0022189 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 5.20e-04 | 206 | 143 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | free cholesterol in large HDL measurement | 5.99e-04 | 79 | 143 | 4 | EFO_0022157 | |
| Disease | cholesterol in large HDL measurement | 6.29e-04 | 80 | 143 | 4 | EFO_0021900 | |
| Disease | 1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6) measurement | 6.41e-04 | 8 | 143 | 2 | EFO_0800392 | |
| Disease | common bile duct neoplasm (is_marker_for) | 6.41e-04 | 8 | 143 | 2 | DOID:4608 (is_marker_for) | |
| Disease | NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO | 6.41e-04 | 8 | 143 | 2 | C3891448 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 6.51e-04 | 215 | 143 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | creatinine measurement, chronic kidney disease | 6.51e-04 | 35 | 143 | 3 | EFO_0003884, EFO_0004518 | |
| Disease | serum metabolite measurement | TNPO1 SORBS2 APOB SMOC1 ABCA7 CDK10 PACRGL ERAP2 PCIF1 DOCK6 FAM20A MAP4K2 MUSK | 7.13e-04 | 945 | 143 | 13 | EFO_0005653 |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 7.34e-04 | 220 | 143 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | non-high density lipoprotein cholesterol measurement | TNPO1 USP34 DNAH10 WDR81 PEX6 DDX56 APOB SLC34A1 PCIF1 ASCC3 MUSK | 7.35e-04 | 713 | 143 | 11 | EFO_0005689 |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 8.06e-04 | 224 | 143 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 8.06e-04 | 224 | 143 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 8.25e-04 | 225 | 143 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 8.25e-04 | 86 | 143 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 9.03e-04 | 229 | 143 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 9.18e-04 | 153 | 143 | 5 | EFO_0004611, EFO_0020944 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.00e-03 | 321 | 143 | 7 | EFO_0004612, EFO_0004639 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.02e-03 | 91 | 143 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | cardiovascular system disease (is_marker_for) | 1.02e-03 | 10 | 143 | 2 | DOID:1287 (is_marker_for) | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.11e-03 | 42 | 143 | 3 | EFO_0022255 | |
| Disease | cytochrome p450 3a4 measurement | 1.25e-03 | 11 | 143 | 2 | EFO_0020303 | |
| Disease | level of Sphingomyelin (d34:0) in blood serum | 1.25e-03 | 11 | 143 | 2 | OBA_2045176 | |
| Disease | hematocrit | RIPK3 HLF AFF3 PEX6 EXOC3 ZC3HC1 APOB CDK10 LRRC47 ARHGEF40 SLC34A1 PDILT MUSK | 1.31e-03 | 1011 | 143 | 13 | EFO_0004348 |
| Disease | apolipoprotein B measurement | 1.51e-03 | 663 | 143 | 10 | EFO_0004615 | |
| Disease | cholesteryl ester measurement | 1.63e-03 | 257 | 143 | 6 | EFO_0010351 | |
| Disease | HbA1c measurement | 1.72e-03 | 675 | 143 | 10 | EFO_0004541 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.73e-03 | 260 | 143 | 6 | EFO_0008317 | |
| Disease | human Chorionic Gonadotropin measurement | 1.76e-03 | 13 | 143 | 2 | EFO_0008156 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 1.76e-03 | 13 | 143 | 2 | OBA_2045159 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.79e-03 | 106 | 143 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.86e-03 | 264 | 143 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | body mass index, fasting blood glucose measurement | 1.96e-03 | 51 | 143 | 3 | EFO_0004340, EFO_0004465 | |
| Disease | sulfate measurement | 2.04e-03 | 14 | 143 | 2 | EFO_0007864 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.05e-03 | 110 | 143 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 2.25e-03 | 274 | 143 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 2.35e-03 | 15 | 143 | 2 | EFO_0022328 | |
| Disease | antihyperlipidemic drug use measurement | 2.41e-03 | 115 | 143 | 4 | EFO_0803367 | |
| Disease | triglycerides in medium VLDL measurement | 2.43e-03 | 55 | 143 | 3 | EFO_0022155 | |
| Disease | HOMA-B | 2.43e-03 | 55 | 143 | 3 | EFO_0004469 | |
| Disease | cholesterol to total lipids in large HDL percentage | 2.43e-03 | 55 | 143 | 3 | EFO_0022234 | |
| Disease | vitamin C measurement | 2.68e-03 | 16 | 143 | 2 | EFO_0600003 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 2.81e-03 | 120 | 143 | 4 | EFO_0004611, EFO_0004639 | |
| Disease | sexual dimorphism measurement | RIPK3 DNAH10 TUBG2 TSC2 APOB FRYL SAMHD1 DCAF16 MADD ARHGEF40 AP5B1 PCIF1 KPNA2 | 2.88e-03 | 1106 | 143 | 13 | EFO_0021796 |
| Disease | apolipoprotein A 1 measurement | ACACB DNAH10 AFF3 PEX6 RFX6 APOB TUBG1 MADD PCIF1 DOCK6 MUSK | 2.88e-03 | 848 | 143 | 11 | EFO_0004614 |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 2.90e-03 | 121 | 143 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | triglycerides in VLDL measurement | 2.97e-03 | 59 | 143 | 3 | EFO_0022326 | |
| Disease | Moyamoya Disease | 3.02e-03 | 17 | 143 | 2 | C0026654 | |
| Disease | alpha-L-iduronidase measurement | 3.02e-03 | 17 | 143 | 2 | EFO_0020139 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.02e-03 | 17 | 143 | 2 | EFO_0022232 | |
| Disease | triglycerides to total lipids in large HDL percentage | 3.12e-03 | 60 | 143 | 3 | EFO_0022330 | |
| Disease | pulse pressure measurement | USP34 TRPM7 PCDHA13 FRYL SLC22A7 MADD TGFBR3 PIEZO2 PTPRD ARVCF SMIM38 PITPNM3 ELN MAP4K2 MUSK | 3.17e-03 | 1392 | 143 | 15 | EFO_0005763 |
| Disease | triglycerides in small VLDL measurement | 3.27e-03 | 61 | 143 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 3.27e-03 | 61 | 143 | 3 | EFO_0022274 | |
| Disease | free cholesterol in HDL measurement | 3.27e-03 | 61 | 143 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 3.27e-03 | 61 | 143 | 3 | EFO_0022293 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 3.39e-03 | 18 | 143 | 2 | OBA_2045155 | |
| Disease | phospholipids in large VLDL measurement | 3.42e-03 | 62 | 143 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 3.42e-03 | 62 | 143 | 3 | EFO_0022322 | |
| Disease | total lipids in HDL measurement | 3.58e-03 | 63 | 143 | 3 | EFO_0022307 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CVDLLPRPHLQELIV | 631 | Q68DN1 | |
| DLTLLSRIPEHLPQE | 771 | P51826 | |
| QPDLLLLRHVPLTRV | 871 | Q96Q91 | |
| DPPLVQRLLILIHDD | 616 | Q8TER5 | |
| QRLLILIHDDLPTEL | 621 | Q8TER5 | |
| GLPLLVALLDHPRAE | 401 | O00192 | |
| RLAVEVLHAADLLPL | 1026 | O94812 | |
| RHPDLSIPELLRIVQ | 361 | P43652 | |
| VARILLTPPEHLERT | 191 | P22570 | |
| ALLARALVHLSLVPP | 556 | Q3MIX3 | |
| LPPVRLAELHADLKI | 71 | P30533 | |
| ILDLDLHLPLLCFRP | 186 | A2RUS2 | |
| RDLTPEHLPLLRNIL | 231 | Q96C86 | |
| LDPSTPVHILREIGL | 81 | Q9NXF7 | |
| LVEELPHELVLVLPY | 1091 | Q8IZY2 | |
| LLSLLLLVPVHPQRL | 26 | Q16790 | |
| PPELELLSLEAVHRA | 471 | O95072 | |
| VHLVDKLPLPIALRS | 206 | Q12829 | |
| VHLVDKLPLPIALRS | 206 | P0C0E4 | |
| HLLPLLENPVIIDIF | 301 | Q8HWS3 | |
| NLRVIKLILLHETPP | 371 | Q8TE59 | |
| PELLSLVHLDAVPRP | 216 | Q0D2K2 | |
| HGLLIPLLLIELETV | 376 | Q6ZRR7 | |
| HVLPLEAGLTPDILI | 681 | Q12851 | |
| TLRHPSLPLLELQEI | 1031 | O00763 | |
| RRPDSLQHVLLPVLD | 161 | P00746 | |
| PELRAHVIDKFLLLP | 276 | P51606 | |
| SRLPLLLTHEGVLLP | 11 | Q86WA8 | |
| TLVDFPLHLPLELLG | 291 | Q8WXG6 | |
| PTPLRAHDILHLVEL | 151 | Q6ZVK8 | |
| PDLFRDLEIIPALLH | 201 | Q9HA64 | |
| PPLDLRNLSIIREHA | 451 | Q8WWW8 | |
| TLEPLLARSPFLVLH | 691 | Q15034 | |
| RLLLRVLHVSENPVP | 306 | Q8N1G4 | |
| LQLLRHDLPLHPAVV | 471 | Q9NY93 | |
| LHALTRPPALLLLAA | 36 | Q8WUY8 | |
| HEALLTLVVPPALLL | 671 | P26006 | |
| LIHPPERSDLTLYLI | 681 | Q9Y5F6 | |
| IQLPLEHPELLSLGL | 721 | Q13608 | |
| IELVDLKPLPTARRH | 1316 | O94915 | |
| ALIHRDLKPPNLLLV | 151 | O43318 | |
| AIHLPPDSKLLLRLE | 831 | Q2VPB7 | |
| VLRSLLENPLKLPLH | 21 | Q16534 | |
| LLLVVAPPRVAALVH | 21 | A1L453 | |
| EPPISLDLTFHLLRE | 156 | P06850 | |
| DGPLRLLLLPSIHLE | 361 | Q8IZL8 | |
| LLLCLLPLVRATEPH | 6 | Q9NYM4 | |
| PLDEVDAPHHRLLVL | 636 | Q9Y5I0 | |
| QILPTLVRLLHHDDP | 251 | P52292 | |
| PIILHLNFSLVREPI | 726 | Q13349 | |
| EVLERHEPLPAKLAL | 66 | Q06495 | |
| PLLRPERKADLIIHL | 711 | Q3MJ16 | |
| LVLPPTREVHLILSF | 396 | Q9UP65 | |
| SLELPVLHVPRNLKL | 3301 | P04114 | |
| PLLHELLTHVRLPLL | 246 | Q6TFL4 | |
| DLEPRKVHLPELLRS | 221 | Q9H0H3 | |
| FLHQDLPLLVLPRQI | 486 | Q9BX69 | |
| PPHPEVELLRSQLIL | 196 | Q9H4Z3 | |
| LPLLSIARDTLPRLH | 1166 | Q96HP0 | |
| ELLAHRPLLPGTSEI | 231 | Q15131 | |
| HPALRSLRLLTLEQP | 66 | Q86VU5 | |
| HSHLECREPLLIPIL | 181 | Q9HCJ1 | |
| IQDLIPVLLRHRLCP | 466 | Q96D53 | |
| LLPFVRIEHILPINS | 516 | Q9P203 | |
| REAPVPSLHLKLLSV | 81 | Q9GZN8 | |
| LRPALRLPSLLLVHV | 526 | P35475 | |
| DLLPSRDRQHLPLIK | 211 | P02671 | |
| EVLALPELPSAHPII | 1286 | O75064 | |
| ELRLPSVVIPLHYDL | 66 | Q6P179 | |
| KLFTIERLHLPPDLS | 376 | Q96EB1 | |
| SSTHVPLVLPLLVLL | 6 | Q6NUI6 | |
| TLEPLLSPHVVSELL | 366 | O60645 | |
| LSQLPPELLLVVLSH | 26 | Q8NI29 | |
| PDLDRIIPVLLEHGL | 511 | P18858 | |
| IIPVLLEHGLERLPE | 516 | P18858 | |
| DLPILKIIPIEAHRL | 4406 | Q8IVF4 | |
| PGVLLLLLSILHPSR | 11 | P15502 | |
| VALLALPRVLLPLHF | 21 | Q9Y694 | |
| VLQLHRVLPPDLKSL | 16 | Q9NRP4 | |
| LVLLPLPIVLHTKEA | 21 | Q9BZW2 | |
| LHQARLLALLVIPPA | 216 | Q9BWS9 | |
| VPHRLLTLTLLPSLE | 231 | Q9BT04 | |
| PLDREETPNHKLLVL | 346 | Q9BZA8 | |
| LPRLIPVLKAALVHS | 156 | Q8N7B6 | |
| PIPILELADHIERLK | 1336 | P23468 | |
| PIIIHRLLPHAVSSL | 256 | Q9UBD5 | |
| ADHVRLLVPLVLEPG | 191 | Q96C03 | |
| PVHILEERSLLVLTP | 36 | Q8N807 | |
| QSPHGIPIDLLDRLL | 341 | Q9Y230 | |
| LLDIDPLILIHLLDL | 611 | O94972 | |
| PLLSLVLAHCDLPEL | 541 | Q13671 | |
| THILNRVLPPDIRIL | 161 | Q9BZE2 | |
| PVTPLHLDLTQLHRL | 421 | Q494U1 | |
| LDVLLLHRLVLLEVP | 171 | O60522 | |
| IELHPLLVRIIDTPQ | 126 | Q9Y3Z3 | |
| ALPLLRVLSIRVDHP | 546 | Q15345 | |
| RLLLDIPLQTPHKLV | 1161 | P0DJD1 | |
| LPHRLLTDIISDGVP | 186 | Q9NVX7 | |
| LSPVLTEPHLLALDR | 486 | Q96MK3 | |
| PLLPLDELHVLAEQL | 56 | Q6ZNJ1 | |
| ADHLPPILLLRLIHL | 191 | Q6ZNJ1 | |
| VLLSQLHLPTVLPDR | 136 | Q9BRB3 | |
| PDPLLALLVVILLAR | 11 | A0A286YFK9 | |
| PEEALPFLERLLLLH | 681 | Q8TE82 | |
| RLAVLPPELAHTTEL | 346 | Q14160 | |
| ILHRLISELLPDVPE | 756 | O94875 | |
| LQEELHRLTLPLPKS | 581 | Q96JN2 | |
| ILPERHPPHTELLDL | 1291 | Q8N3C0 | |
| PLLRDPALDLKVIHL | 316 | Q9Y4C5 | |
| PALDLKVIHLVRDPR | 321 | Q9Y4C5 | |
| PLLSDPALNLRIVHL | 186 | Q9GZX3 | |
| PDLILVHPVLALSGR | 16 | Q9BTD1 | |
| HLDLQLPSLRPEDLK | 191 | Q86WB0 | |
| LLKEFLHLDLTAPIP | 561 | O94827 | |
| TPHLLLVLVQLSPAR | 11 | Q9H4F8 | |
| LLVLEQFLSVLPPHL | 31 | Q96SZ4 | |
| LLPLLLLLHTCVPAS | 6 | Q03405 | |
| RLQVLHLLILILPEP | 381 | Q5TG30 | |
| HLLILILPEPNRNAL | 386 | Q5TG30 | |
| RTLPATVPLLLQHIL | 1386 | Q99973 | |
| DDRVKLTEHLIPLLP | 571 | Q9UJ98 | |
| PVLLHRDLKPSNVLL | 136 | Q9Y572 | |
| IPRAVLLDLEPRVIH | 61 | P23258 | |
| HRLRVPLPTELLVIV | 286 | Q9H2B4 | |
| PRVLLQTLRHPIFLL | 361 | O94956 | |
| QLLLPSLLDLHLPRF | 301 | Q86U17 | |
| HELILDFIRSRPPLK | 311 | Q8WWL2 | |
| VFREELLPHLLPLLK | 386 | O14787 | |
| LLKPLVHLQLPRSDL | 131 | Q9NUY8 | |
| LPPLTHELTASELLL | 1871 | Q9H5I5 | |
| PSRPVLHLLQLLLRT | 791 | Q96DN2 | |
| HEILSRDPLLLAIIP | 381 | Q9HAV4 | |
| PHLLSPLLQLLRALV | 441 | Q5SRE5 | |
| HRILEPGLNILIPVL | 56 | Q9UJZ1 | |
| HQEARFLIPLLVPLV | 386 | Q86VD9 | |
| LHRGELQRVPTLLLP | 1076 | Q9BWH6 | |
| ELLPHILPLLKELLF | 401 | Q92973 | |
| ASRLEPLLEPKFHLV | 441 | Q9BZ71 | |
| IRQLVRIDHIPDLPL | 526 | O14512 | |
| SPLLPLHEEVEALLF | 2376 | Q9UPU5 | |
| PPSLVQLILLSRIIH | 1341 | Q01118 | |
| IPRAVLLDLEPRVIH | 61 | Q9NRH3 | |
| SLIKNLDPVPLRHLL | 431 | Q70CQ2 | |
| ALHDPRVSPELLLGV | 71 | Q658N2 | |
| LLSLPDHPIAQLLRR | 276 | Q9Y2B5 | |
| RRPHDPKTVDLILEL | 46 | Q07283 | |
| LVRALPLALVLHELG | 391 | P19971 | |
| SPPELRQRLHGVELL | 1361 | Q96QT4 | |
| APPFIVISHLRLLLR | 1076 | Q8TD43 | |
| PRISHEVLLPVLSFL | 1366 | Q562E7 | |
| EVHTIPPELRILLDP | 366 | Q03167 | |
| PERPLEARHAVLALL | 91 | P49815 | |
| VPLLEFLSTLARLPH | 841 | P49815 | |
| VVPLPDHLCRDDILL | 216 | B1ANS9 | |
| LTTLPSELLLDRLHP | 536 | O15146 |